Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-FLT PET and MRI for Breast Lesion Diagnosis
NCT01956890Phase 4Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Jun 2011
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of fluorothymidine F-18 in breast cancer, sponsored by National Taiwan University Hospital. Primary endpoint: diagnostic accuracy of 18F-FLT PET and MRI at 5 years. Status: unknown.
02
Drugs
fluorothymidine F-18
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01956890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01956890.